Since excessive collagen deposition may lead to the development of intestinal fibrosis, FRB seemingly reduced the risk of fibrosis due to DSS-induced colitis, by reducing the mRNA expression of Col1a1 and Col1a2 and increasing the level of Mmp3 (Figure 7A,B,D). Here, COL1A2 is linked to colitis.